Valuation: Lactose (India) Limited

Market Cap 1.01B 10.59M 9.08M 8.48M 7.78M 14.64M 14.88M 100M 39.2M 508M 39.77M 38.9M 1.68B P/E 2024
25.9x
P/E 2025 21.8x
Enterprise Value 1.54B 16.07M 13.78M 12.87M 11.81M 22.2M 22.57M 152M 59.47M 770M 60.33M 59.02M 2.55B EV / Sales 2024
1.87x
EV / Sales 2025 1.41x
Free-Float
41.28%
Yield 2024 *
-
Yield 2025 -
1 day-0.05%
1 week-13.05%
Current month-4.78%
1 month-1.34%
3 months-11.94%
6 months+3.28%
Current year-2.92%
1 week 98.6
Extreme 98.6
108.9
1 month 93
Extreme 93
117.8
Current year 76.01
Extreme 76.01
136.45
1 year 76.01
Extreme 76.01
136.7
3 years 56.53
Extreme 56.53
247.4
5 years 33.1
Extreme 33.1
247.4
10 years 14.35
Extreme 14.35
247.4
Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 59 2016-05-27
Chief Operating Officer - -
Director TitleAgeSince
Chairman 61 -
Director/Board Member 59 2014-01-23
Director/Board Member 65 2024-08-07
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-13.05%+2.03%+45.76% 13.09M
+0.18%-1.04%+9.87%-23.61% 251B
+2.39%+3.85%+3.75%-9.80% 79.97B
+0.31%-2.41%-8.40%+23.48% 48.77B
-1.43%+0.37%+35.34%-2.50% 39.74B
+2.91%+3.74%+5.82%-13.71% 36.86B
-4.61%+0.15%+29.06%+84.26% 33.1B
+0.41%-1.35%+28.50%+34.65% 29.46B
+3.46%+4.18%-5.83%-23.71% 29.43B
-0.31%+2.15%+41.49%+1.31% 21.97B
Average +0.33%-0.58%+14.17%+11.61% 57B
Weighted average by Cap. +0.45%-0.01%+11.45%-5.30%

Financials

2024 2025
Net sales 1.14B 11.92M 10.22M 9.54M 8.76M 16.47M 16.74M 113M 44.1M 571M 44.74M 43.77M 1.89B 1.16B 12.18M 10.45M 9.75M 8.95M 16.83M 17.11M 115M 45.07M 584M 45.73M 44.73M 1.93B
Net income 67.89M 710K 609K 569K 522K 982K 998K 6.71M 2.63M 34.05M 2.67M 2.61M 113M 51.63M 540K 463K 433K 397K 746K 759K 5.11M 2M 25.89M 2.03M 1.98M 85.61M
Net Debt 377M 3.95M 3.39M 3.16M 2.9M 5.45M 5.54M 37.3M 14.61M 189M 14.82M 14.5M 626M 523M 5.48M 4.7M 4.39M 4.02M 7.57M 7.69M 51.76M 20.27M 263M 20.56M 20.12M 868M
Logo Lactose (India) Limited
Lactose (India) Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It specializes in manufacturing of lactose monohydrate IP/BP/EP/USP-NF grades. The Company’s lactose products include Formulac 200M, Formulac 80M, Formulac 100M, Formulac 325M, Formulac DC60, Formulac 450M, Formulac 314M and Formulac DC2050. It is also engaged in the manufacturing of disaccharide lactulose, a versatile bulk API. Disaccharide Lactulose (galacto-fructose) is synthesized from lactose (galacto-glucose) by isomerization of glucose to fructose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic.
Employees
140
Date Price Change Volume
26-08-19 ₹99.60 -0.05% 3,053
26-08-18 ₹99.65 -1.48% 4,930
26-08-17 ₹101.15 -5.86% 17,913
26-08-14 ₹107.45 +1.80% 6,619
26-08-13 ₹105.55 -0.66% 3,181
  1. Stock Market
  2. Stocks
  3. LACTOSE6 Stock